Quantitation and visualization of tumor-specific T cells in the secondary lymphoid organs during and after tumor elimination by PET

Nuclear Medicine and Biology

Volumn 31, Issue 8, 2004, Pages 1021-1031

  Matsui, Ken ^a   Wang, Zheng ^b   McCarthy, Timothy J ^c   Allen, Paul M ^a   Reichert, David E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c PFIZER INC   (United States)

Author keywords

64Cu; CMS5; DOTA; DUC18; Immunotherapy; PET

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; CANCER ANTIBODY; COPPER 64; THY ANTIGEN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL SPECIFICITY; CELL TRANSFER; CELLULAR DISTRIBUTION; CONJUGATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISSOCIATION CONSTANT; GENETIC TRANSFECTION; IMAGE ANALYSIS; IMAGING SYSTEM; INTERMETHOD COMPARISON; ISOTOPE LABELING; LYMPH NODE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; SPLEEN; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; FIBROSARCOMA; IMMUNOTHERAPY, ADOPTIVE; LYMPH NODES; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; SPLEEN; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 10644222780     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2004.06.002     Document Type: Article

References (35)

1. Dudley M.E., Wunderlich J., Nishimura M.I., Yu D., Yang J.C., et al. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother. 24:2001;363-373
2. Dudley M.E., Wunderlich J.R., Robbins P.F., Yang J.C., Hwu P., et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 298:2002;850-854
3. 8+ T cells it may get by with a little help from its friends. J Clin Invest. 110:2002;1415-1417
4. Kawakami Y., Rosenberg S.A. Human tumor antigens recognized by T-cells. Immunol Res. 16:1997;313-319
5. Rosenberg S.A. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity. 10:1999;281-287
6. Rosenberg S.A. Principles and practice of the biologic therapy of cancer. 3rd ed:2000;Lippincott Williams&Wilkins, Philadelphia, PA, USA
7. Rosenberg S.A., Yang J.C., Schwartzentruber D.J., Hwu P., Marincola F.M., et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med. 4:1998;321-327
8. Yee C., Riddell S.R., Greenberg P.D. In vivo tracking of tumor-specific T cells. Curr Opin Immunol. 13:2001;141-146
9. 8+ T cell clones for the treatment of patients with metastatic melanoma in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci USA. 99:2002;16168-16173
10. Yee C., Thompson J.A., Roche P., Byrd D.R., Lee P.P., et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma. Direct evidence of t cell-mediated vitiligo. J Exp Med. 192:2000;1637-1643
11. Mitchell M.S., Darrah D., Yeung D., Halpern S., Wallace A., et al. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J Clin Oncol. 20:2002;1075-1086
12. Bennett J.J., Tjuvajev J., Johnson P., Doubrovin M., Akhurst T., et al. Positron emission tomography imaging for herpes virus infection Implications for oncolytic viral treatments of cancer. Nat Med. 7:2001;859-863
13. Gambhir S.S., Barrio J.R., Phelps M.E., Iyer M., Namavari M., et al. Imaging adenoviraldirected reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA. 96:1999;2333-2338
14. Le L.Q., Kabarowski J.H., Wong S., Nguyen K., Gambhir S.S., et al. Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene. Cancer Cell. 1:2002;381-391
15. Phelps M.E. PET The merging of biology and imaging into molecular imaging. J Nucl Med. 41:2000;661-681
16. Tjuvajev J.G., Avril N., Oku T., Sasajima T., Miyagawa T., et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58:1998;4333-4341
17. Yu Y., Annala A.J., Barrio J.R., Toyokuni T., Satyamurthy N., et al. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med. 6:2000;933-937
18. Kikkawa H., Imafuku H., Tsukada H., Oku N. Possible role of immune surveillance at the initial phase of metastasis produced by B16BL6 melanoma cells. FEBS Lett. 467:2000;211-216
19. Kikkawa H., Tsukada H., Oku N. Usefulness of positron emission tomographic visualization for examination of in vivo susceptibility to metastasis. Cancer. 89:2000;1626-1633
20. Koike C., Watanabe M., Isoai A., Kumagai H., Tsukada H., et al. How platelet aggregation affects B16BL6 melanoma cell trafficking. FEBS Lett. 427:1998;286-290
21. Koike C., Watanabe M., Oku N., Tsukada H., Irimura T., et al. Tumor cells with organspecific metastatic ability show distinctive trafficking in vivo analyses by positron emission tomography and bioimaging. Cancer Res. 57:1997;3612-3619
22. Melder R.J., Brownell A.L., Shoup T.M., Brownell G.L., Jain R.K. Imaging of activated natural killer cells in mice by positron emission tomography preferential uptake in tumors. Cancer Res. 53:1993;5867-5871
23. Melder R.J., Elmaleh D., Brownell A.L., Brownell G.L., Jain R.K. A method for labeling cells for positron emission tomography (PET) studies. J Immunol Methods. 175:1994;79-87
24. Oku N., Koike C., Sugawara M., Tsukada H., Irimura T., et al. Positron emission tomography analysis of metastatic tumor cell trafficking. Cancer Res. 54:1994;2573-2576
25. 64Cu-pyruvaldehyde-bis(N4- methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA. 99:2002;3030-3035
26. Dubey P., Su H., Adonai N., Du S., Rosato A., et al. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci USA. 100:2003;1232-1237
27. Weissleder R. Scaling down imaging molecular mapping of cancer in mice. Nat Rev Cancer. 2:2002;1-8
28. Wipke B.T., Wang Z., Kim J., McCarthy T.J., Allen P.M. Dynamic visualization of a jointspecific autoimmune response through positron emission tomography. Nat Immunol. 3:2002;366-372
29. 64Cu using a biomedical cyclotron. Nucl Med Biol. 24:1997;35-43
30. 8+ T cell adoptive immunotherapy. Immunity. 13:2000;265-276
31. Matsui K., O'Mara L.A., Allen P.M. Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy. Int Immunol. 15:2003;797-805
32. Ikeda H., Ohta N., Furukawa K., Miyazaki H., Wang L., et al. Mutated mitogen-activated protein kinase A tumor rejection antigen of mouse sarcoma. Proc Natl Acad Sci USA. 94:1997;6375-6379
33. Lewis M.R., Kao J.Y., Anderson A.L., Shively J.E., Raubitschek A. An improved method for conjugating monoclonal antibodies with N- hydroxysulfosuccinimidyl DOTA. Bioconj Chem. 12:2001;320-324
34. Meares C.F., McCall M.J., Reardan D.T., Goodwin D.A., Diamanti C.I., et al. Conjugation of antibodies with bifunctional chelating agents isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Anal Biochem. 142:1984;68-78
35. Cohen P.A., Peng L., Kjaergaard J., Plautz G.E., Finke J.H., et al. T-cell adoptive therapy of tumors mechanisms of improved therapeutic performance. Crit Rev Immunol. 21:2001;215-248